X0304 4 2011-12-05 1 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001440766 Dingivan Christine A 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 EVP/Chief Medical Officer Stock Options (to buy) 27.27 2011-12-05 4 D 0 45000 0 D Common Stock 45000 0 D Stock Option (to buy) 26.64 2011-12-05 4 D 0 20000 0 D Common Stock 20000 0 D Stock Option (to buy) 20.45 2011-12-05 4 D 0 41403 0 D Common Stock 41403 0 D Stock Options (to buy) 25.74 2011-12-05 4 D 0 31052 0 D Common Stock 31052 0 D Stock Options (to buy) 19.94 2011-12-05 4 D 0 7763 0 D Common Stock 7763 0 D Stock Options (to buy) 37.69 2011-12-05 4 D 0 7763 0 D Common Stock 7763 0 D Stock Options (to buy) 36.65 2011-12-05 4 D 0 93156 0 D Common Stock 93156 0 D Restricted Stock Units 2011-12-05 4 D 0 15000 0 D Common Stock 15000 0 D The stock options were cancelled pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Product Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger") in exchange for a cash payment equal to the difference (if any ) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12 but vesting was accelerated due to the Merger. These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. The RSUs were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but became fully vested pursuant to the terms of the Agreement. The RSUs were disposed of pursuant to the terms of the Agreement in exchange for a cash payment of $33.25 per share upon the effective date of the Merger. Lisa C. Noecker attorney-in-fact for Christine A. Dingivan 2011-12-06